Cyriel received a prestigious Travel and Merit Award for his abstract, highlighting the impact of his work within the international stem cell research community. The award serves as an important encouragement as he continues working toward translating research into new therapies.

Receiving this award at the ISSCR conference is a wonderful recognition from the international stem cell research community. It encourages me to keep pushing towards the end goal.

– Cyriel

In addition to presenting her research, Bahareh was appointed to the ISSCR Early Career Researcher (ECR) Committee. This international committee represents and supports early-career researchers within the stem cell field and helps shape initiatives for the next generation of scientists.

Over the past year, I served on the ISSCR Early Career Advisory Committee. I am excited to continue contributing to the Society through this new role.

– Bahareh

Alongside these achievements, Cyriel is currently developing a new protocol aimed at hypoparathyroidism, a rare endocrine disorder in which patients lack (functional) parathyroid glands. Similar to people with diabetes who must monitor blood glucose levels, patients with hypoparathyroidism need to monitor their calcium levels and rely on calcium supplementation or parathyroid hormone replacement therapy. The project builds upon the team’s existing type 1 diabetes research pipeline, adapting it to create a potential new therapeutic product for people living with hypoparathyroidism.

In the lab, Bahareh develops cell therapies for patients with type 1 diabetes. Her research focuses on developing an off-the-shelf stem cell-derived islet product, including clinically compliant enrichment and cell banking processes.

We warmly congratulate Cyriel and Bahareh on these achievements and look forward to following their continued contributions to research and the international stem cell community.